Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...

A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...

A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...

Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global ...

Researchers have created a chip that's implanted in the eye, that with the help of AR glasses, can partially restore ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...

Federal judge rules divestiture plan addresses competition concerns in GTCR's acquisition of Surmodics despite FTC claims of ...

Surmodics, Inc. (Nasdaq: SRDX) ("Surmodics" or the "Company"), a leading provider of medical device and in vitro diagnostic ...

The LATAM laboratory equipment and disposables market experienced significant growth in recent years, with a valuation of $1,759 million in 2019. Projections indicate a promising trajectory, with ...